Dear Tom Hale and others Apologies, I didn't realise that Moclobemide wasn't available in the US. Usually Australia is years behind the rest of the world in pharmaceuticals, and I assumed you would be familiar with it. The major difference between Moclobemide (marketed as Aurorix in Aust) and other MAOIs is that this is a reversible monoamine oxidase inhibitor. There are no interactions with foods or narcotics, unlike the older nonreversible inhibitors. It seems a vast improvement on other MAOIs, but as I don't have first hand experience with treating lactating women with it, I can't add more information. I certainly agree with Tom Hale that non-reversible MAOIs are not compatible with lactation, and they are rarely used at all in Australia due to their side effects etc. Fiona Coombes MBBS IBCLC Perth Western Australia Another hot day - off to the pool again!!